Skip to main content

Table 1 Clinicopathological correlation of ARNTL2 expression in human ccRCC

From: Upregulation of ARNTL2 is associated with poor survival and immune infiltration in clear cell renal cell carcinoma

Characteristic Low expression of ARNTL2 High expression of ARNTL2 pa
n 269 270  
Age, n (%)    0.518
 <=60 130 (24.1%) 139 (25.8%)  
 >60 139 (25.8%) 131 (24.3%)  
Gender, n (%)    0.903
 Female 94 (17.4%) 92 (17.1%)  
 Male 175 (32.5%) 178 (33%)  
T stage, n (%)    0.027
 T1–T2 183 (33.9%) 166 (30.8%)  
 T3–T4 86 (16%) 95 (19.3%)  
N stage, n (%)    0.034
 N0 119 (46.3%) 122 (47.5%)  
 N1 3 (1.2%) 13 (5.1%)  
M stage, n (%)    0.118
 M0 220 (43.5%) 208 (41.1%)  
 M1 32 (6.3%) 46 (9.1%)  
Pathologic stage, n (%)    0.031
 Stage I–II 174 (32.5%) 157 (29.3%)  
 Stage III–IV 95 (17.7%) 110 (20.6%)  
Histologic grade, n (%)    0.012
 G1–3 233 (43.9%) 223 (42%)  
 G4 31 (5.8%) 44 (8.3%)  
  1. ap-values were derived from chi-square test